Abstract:Chenhui Wang, 1 Lei Han, 2 Yuru Li, 2 Xibin Mi, 3 Mengwei Yan, 4 Xinxiu Yu, 2 Yu Lu, 2 Meihong Shi, 2 Pengfei Liu, 2 Liang Han, 2 Baoguo Wang 1 1 Department of Anesthesiology, Sanbo Brain Hospital, Capital Medical University, Beijing, People's Republic of China; 2 Infirmary, Taikang Yanyuan Continuing Care Retirement Community, Beijing, People's Republic of China; 3 Department of Pain Management, Yanyuan Rehabilitation Hospital, Beijing, People's Republic of China; 4 Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Capital Medical University, Beijing, People's Republic of China Correspondence: Baoguo Wang, Department of Anesthesiology, Sanbo Brain Hospital, Capital Medical University, No. 50 Yikesong Street, Haidian District, Beijing, 100095, People's Republic of China, Tel/Fax +86 10 6285 6766, Email Purpose: To identify the prevalence of exacerbation of pre-existing chronic pain after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and investigate the impact of exacerbated previous chronic pain on quality of life, sleep quality, anxiety and depression levels and risk factors associated with exacerbated chronic pain among elderly coronavirus disease of 2019 (COVID-19) survivors. Patients and Methods: In this cross-sectional study, elderly COVID-19 survivors with chronic pain residing in Continuing Care Retirement Community (CCRC) were recruited from April 2023 to June 2023. Eligible individuals were divided into exacerbation and non-exacerbation groups based on the patient-reported worsening symptoms of previous chronic pain after SARS-CoV-2 infection. Baseline information, COVID-19 symptoms, laboratory parameters, characteristics of exacerbated chronic pain, quality of life, anxiety and depression levels were systematically collected. Results: Ninety-five (95/441, 21.5%) older adults suffered from exacerbated chronic pain with a median numerical rating scale (NRS) score of 6 (4– 7) on a median duration of 4.9 (4.3– 5.6) months after SARS-CoV-2 infection. More participants were not vaccinated against COVID-19 (46.5%, 40/86 vs 26.1%, 86/330, P < 0.001) in exacerbation group. Exacerbation group exhibited poor quality of life (EQ5D index: 0.734 [0.536– 0.862] vs 0.837 [0.716– 0.942], P < 0.001), more severe anxiety (GAD-7: 2 [0– 5] vs 0 [0– 3], P < 0.001) and depression (PHQ-9: 4 [2– 7] vs 2.5 [0– 5], P < 0.001) than non-exacerbation group. Risk factors significantly associated with exacerbation of pre-existing chronic pain were neuropathic pain (aOR 4.81, 95% CI 1.73– 13.32, P = 0.003), lymphocyte count (aOR 0.31, 95% CI 0.12– 0.78, P = 0.013) and D-dimer levels (aOR 6.46, 95% CI 1.92– 21.74, P = 0.003). Conclusion: Our study observed a prevalence of 21.5% exacerbation of pre-existing chronic pain after SARS-CoV-2 infection, with a consequence of poor quality of life, more severe anxiety and depression. Previous chronic neuropathic pain, lower lymphocyte count and higher D-dimer levels were risk factors associated with the development of exacerbated previous chronic pain. Keywords: post-COVID-19, older adults, chronic pain, exacerbated symptoms After the coronavirus disease of 2019 (COVID-19) pandemic, attention has shifted towards the enduring alterations within multiple biological systems triggered by the infection of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). 1,2 The distinctive manifestation of post-COVID-19 condition (PCC) was post-COVID pain and exacerbated symptoms of previous chronic pain. 3 Several observational studies have investigated the new-onset musculoskeletal pain symptoms and risk factors correlated with post-COVID pain among COVID-19 survivors. 4,5 Approximately 15.1% to 45.1% of COVID-19 survivors suffered from post-COVID pain, 6,7 and a correlation was found between prognostic serological biomarkers (eg, lymphocyte count, D-dimer levels, C-reactive protein concentration and glucose levels) and long-term post-COVID pain. 1,4 Conversely, only two studies have highlighted the exacerbation of pre-existing pain among middle-aged and hospitalized patients after SARS-CoV-2 infection, indicating a prevalence of 25.1% and 66.6%, respectively. 2,6 As the virulence and transmission of SARS-CoV-2 continue to evolve, 8 an increasing number of people are facing the problem of SARS-CoV-2 infection. Among them, the elderly are more susceptible to COVID-19 due to waning immune functions and are prone to the development of chronic pain because of troubles caused by degenerative o -Abstract Truncated-

Impact of chronic pain on numerous long COVID-like symptoms: A large-scale internet-based epidemiological study in Japan

Prevalence and trends in persistent symptoms following COVID-19 in Japan: A nationwide cross-sectional survey

Considering the potential for an increase in chronic pain after the COVID-19 pandemic

Symptoms of post COVID-19 condition and diseases/conditions diagnosed after COVID-19 in Japanese patients: A real-world study using a claims database

Predictors of somatic symptoms during the COVID-19 pandemic: a national longitudinal survey in Japan

Symptoms and risk factors for long COVID in non-hospitalized adults

Consistency of inconsistency in long‐COVID‐19 pain symptoms persistency: A systematic review and meta‐analysis

Attributes and predictors of long COVID

Cross-sectional surveillance study of long COVID in Toyonaka city, Osaka prefecture, Japan

The impact of COVID-19 infection on musculoskeletal pain and its associating factors: a cross-sectional study

Characterizing long COVID in an international cohort: 7 months of symptoms and their impact

Chronic obstructive pulmonary disease, asthma, and mechanical ventilation are risk factors for dyspnea in patients with long COVID: A Japanese nationwide cohort study

Impact of Long COVID on Health-Related Quality of Life Among Patients After Acute COVID-19 Infection: A Cross-Sectional Study

Exacerbation of Pre-Existing Chronic Pain in Older Adults After SARS-CoV-2 Infection: A Single-Center, Cross-Sectional, Observational Study

Prevalence, Risk Factors and Pain Subtypes of Post-COVID Pain in Nonhospitalized Older Adults: A Cross-Sectional Study

Comprehensive analysis of long COVID in a Japanese nationwide prospective cohort study

Genetic overlap and causality between COVID-19 and multi-site chronic pain: the importance of immunity

Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19

Causal relationship between COVID-19 and chronic pain: A mendelian randomization study

Comparing personality traits of healthcare workers with and without long COVID: Cross-sectional study

Fatigue can influence the development of late-onset pain in post-COVID-19 syndrome: An observational study